Directory
>
Axel Schleyer D
Axel Schleyer D
Chief Commercial Officer (CCO) | Cytovance Biologics
San Francisco, California, United States
Axel Schleyer D
Summary
Axel Schleyer is an accomplished Chief Commercial Officer with over two decades of experience in the pharmaceutical and biotechnology sectors. He has a proven track record of driving substantial company growth and managing full P&L responsibilities. Axel excels in crafting and executing strategic business plans across diverse markets, particularly in the life sciences. His leadership style emphasizes collaboration and empowerment, fostering high-performance teams. With a strong scientific foundation in chemistry and biology, he has successfully negotiated significant technology licensing and development agreements. Axel's extensive network within the industry enables him to identify and capitalize on new business opportunities. His expertise spans drug development, commercialization, and international business development, making him a key player in the field. Notably, he has raised over $100 million in capital from elite investors, underscoring his capability in financial strategy. Axel's experience is complemented by advanced degrees in chemistry and business administration, equipping him with a unique blend of technical and commercial acumen.
Axel Schleyer D
Work Experience
Chief Commercial Officer (CCO) at
Cytovance Biologics
August 2023 - Present
Senior Vice President Business Development at
STELIS BIOPHARMA (MALAYSIA) SDN. BHD.
June 2022 - July 2023
President and CEO at
Aragen Bioscience
April 2019 - May 2022
Senior Vice President, Business Development and Key Account Management - Americas & Asia/Pacific at
AGC Biologics
January 2018 - April 2019
Vice President Business Development and Key Account Management, Americas & Asia/Pacific at
Boehringer Ingelheim (schweiz) Gmbh
March 2014 - December 2017
Vice President Business Development and Key Account Management, Americas at
Boehringer Ingelheim (schweiz) Gmbh
October 2010 - February 2014
Director, Business Development at
Baxter Mexico, S. de R.L. de C.V.
February 2006 - October 2010
Director, Sales & Business Development at
Siegfried
October 2004 - September 2005
Consultant & Director, Business Development at
A-BIO PHARMA PTE. LTD.
April 2004 - September 2004
Associate Director, Business Development at
Lonza
January 2000 - March 2004
Scientist at
Kosan Biosciences
June 1998 - December 1999
Scientist at
The Scripps Research Institute
November 1996 - May 1998
Scientist at
Carlsberg Breweries
January 1995 - January 1996
Axel Schleyer D
Education
California State University, Mba
January 1997 - January 1999
The Scripps Research Institute, Postdoctoral Studies
January 1996 - January 1998
University of Hamburg, Ph.D.
January 1993 - January 1996
Frequently Asked Questions about Axel Schleyer D
What is Axel Schleyer D email address?
Axel Schleyer D's primary email address is *********@cytovance.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Axel Schleyer D work for?
Axel Schleyer D is a Chief Commercial Officer (CCO) at Cytovance Biologics, a company specializing in Commercial physical research.
Where Axel Schleyer D graduated from?
Axel Schleyer D holds a degree in Business Administration from California State University.
How can I directly contact Axel Schleyer D?
To contact Axel Schleyer D directly, you can use the email address *********@cytovance.com. Complete contact information is available upon registration with Muraena.
Who is Axel Schleyer D?
Axel Schleyer is an accomplished Chief Commercial Officer with over two decades of experience in the pharmaceutical and biotechnology sectors. He has a proven track record of driving substantial company growth and managing full P&L responsibilities. Axel excels in crafting and executing strategic business plans across diverse markets, particularly in the life sciences. His leadership style emphasizes collaboration and empowerment, fostering high-performance teams. With a strong scientific foundation in chemistry and biology, he has successfully negotiated significant technology licensing and development agreements. Axel's extensive network within the industry enables him to identify and capitalize on new business opportunities. His expertise spans drug development, commercialization, and international business development, making him a key player in the field. Notably, he has raised over $100 million in capital from elite investors, underscoring his capability in financial strategy. Axel's experience is complemented by advanced degrees in chemistry and business administration, equipping him with a unique blend of technical and commercial acumen.
Axel`s contact details
*********@cytovance.com
*************@stelis.com
*************@baxter.com
Colleagues
Chief Executive Officer
Executive Director, Quality Control
Chief Operating Officer